You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 89 No. 3, MARCH 1952 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

CLINICAL USE OF FAT INJECTED INTRAVENOUSLY

THEODORE B. VAN ITALLIE, M.D.; WILLIAM R. WADDELL, M.D.; ROBERT P. GEYER, Ph.D.; FREDRICK J. STARE, Ph.D., M.D.

AMA Arch Intern Med. 1952;89(3):353-357.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

A MAJOR problem in parenteral feeding is associated with the need for a nonsclerosing preparation for intravenous administration which contains a large supply of calories in a small volume of fluid. Fat emulsions appear to offer a solution to this problem. Fat particles do not exert an osmotic effect; accordingly, fat may be injected in high concentrations without damage to veins and in a relatively small fluid volume. Unlike dextrose and amino acids, fat is not excreted in the urine in significant amounts.

Among the earliest clinical studies involving the intravenous administration of fat emulsions for caloric purposes was one reported by Yamakawa in Japan in 1920.1 Later, in this country, Holt, Tidwell, and Scott2 studied the effect of intravenous fat administration in experimental animals and in children.

In the interim, although fat emulsions for intravenous administration still have not become available commercially, their use in man is . . . [Full Text PDF of this Article]


Author Affiliations

BOSTON

From the Department of Nutrition, Harvard School of Public Health, the Medical and Surgical Clinics, Peter Bent Brigham Hospital, and the Surgical Service, Massachusetts General Hospital.


Footnotes

Read before the Section on Experimental Medicine and Therapeutics at the One-Hundredth Annual Session of the American Medical Association, Atlantic City, June 13, 1951.

This study was supported in part by Grants-in-Aid from the Upjohn Company, Kalamazoo 99, Mich.; the Nutrition Foundation, New York; the Cancer Research Grants Branch, National Cancer Institute, Bethesda, Md.; Armour & Company, Chicago, and under contract with the United States Army Research and Development Board of the Surgeon General's Office, Washington, D. C.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1952 American Medical Association. All Rights Reserved.